Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial

Dongliang Bian(Tongji University), Peng Zhang(Tongji University), Wenxin He(Tongji University), Gening Jiang(Tongji University), Deping Zhao(Second Military Medical University), Xinsheng Zhu(Tongji University), Liang Duan(Dalian Medical University), Lei Jiang(Yuhuangding Hospital), Jie Huang(Shanghai Pulmonary Hospital), Yirui Zhou(Tongji University), Xiaogang Liu(Tongji University), Jing Liu(Tongji University), Dong Xie(Shanghai University of Traditional Chinese Medicine), Lele Zhang(Tongji University), Liangdong Sun(Tongji University), Zhida Huang(Fujian Medical University), Jie Yang(Tongji University), Jing Zhang(University of South Dakota), Yue Liu(Ningxia Medical University), Chunyan Wu(Wenzhou Medical University), Junjie Hu(Tongji University), Xiao Bao(People's Hospital of Yangzhong), Yuming Zhu(Third People 's Hospital of Chongqing), Ming Liu(Tongji University), Shuyu Ji(Tongji University)
Nature Communications
April 2, 2025
Cited by 11


Related Papers